Literature DB >> 32562209

Everolimus-Induced Remission of Classic Kaposi's Sarcoma Secondary to Cryptic Splicing Mediated CTLA4 Haploinsufficiency.

Jin Yan Yap1, Brian Gloss2, Marcel Batten1, Peter Hsu3, Lucinda Berglund4, Fenfen Cai4, Pei Dai1,4,5, Andrew Parker6, Min Qiu6, Wendell Miley7, Romin Roshan7, Vickie Marshall7, Denise Whitby7, Eric Wegman8, Roger Garsia9, Kathy H C Wu5,10,11, Edwin Kirk12, Mark Polizzotto5,13, Elissa K Deenick1,5, Stuart G Tangye1,5, Cindy S Ma1,5, Tri Giang Phan14,15.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32562209      PMCID： PMC8996434          DOI： 10.1007/s10875-020-00804-8

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  22 in total

1.  Paradoxical simultaneous regression and progression of lesions in a phase II study of everolimus in classic Kaposi sarcoma.

Authors:  S Mourah; R Porcher; M Battistella; D Kerob; B Guillot; T Jouary; F Agbalika; F Morinet; V Furlan; H M Teisserenc; N Dupin; C Lebbé
Journal:  Br J Dermatol       Date:  2015-08-19       Impact factor: 9.302

2.  Efficient and Accurate Quantitative Profiling of Alternative Splicing Patterns of Any Complexity on a Laptop.

Authors:  Timothy Sterne-Weiler; Robert J Weatheritt; Andrew J Best; Kevin C H Ha; Benjamin J Blencowe
Journal:  Mol Cell       Date:  2018-09-13       Impact factor: 17.970

Review 3.  CHAI and LATAIE: new genetic diseases of CTLA-4 checkpoint insufficiency.

Authors:  Bernice Lo; Jill M Fritz; Helen C Su; Gulbu Uzel; Michael B Jordan; Michael J Lenardo
Journal:  Blood       Date:  2016-07-14       Impact factor: 22.113

4.  Leflunomide with low-dose everolimus for treatment of Kaposi's sarcoma in a renal allograft recipient.

Authors:  Gopal Basu; Anjali Mohapatra; Marie Therese Manipadam; Sunithi Elizabeth Mani; George Tharayil John
Journal:  Nephrol Dial Transplant       Date:  2011-07-20       Impact factor: 5.992

5.  Persistent expansion, in a human immunodeficiency virus-infected person, of V beta-restricted CD4+CD8+ T lymphocytes that express cytotoxicity-associated molecules and are committed to produce interferon-gamma and tumor necrosis factor-alpha.

Authors:  L Weiss; A Roux; S Garcia; C Demouchy; N Haeffner-Cavaillon; M D Kazatchkine; M L Gougeon
Journal:  J Infect Dis       Date:  1998-10       Impact factor: 5.226

6.  Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4.

Authors:  Hye Sun Kuehn; Weiming Ouyang; Bernice Lo; Elissa K Deenick; Julie E Niemela; Danielle T Avery; Jean-Nicolas Schickel; Dat Q Tran; Jennifer Stoddard; Yu Zhang; David M Frucht; Bogdan Dumitriu; Phillip Scheinberg; Les R Folio; Cathleen A Frein; Susan Price; Christopher Koh; Theo Heller; Christine M Seroogy; Anna Huttenlocher; V Koneti Rao; Helen C Su; David Kleiner; Luigi D Notarangelo; Yajesh Rampertaap; Kenneth N Olivier; Joshua McElwee; Jason Hughes; Stefania Pittaluga; Joao B Oliveira; Eric Meffre; Thomas A Fleisher; Steven M Holland; Michael J Lenardo; Stuart G Tangye; Gulbu Uzel
Journal:  Science       Date:  2014-09-11       Impact factor: 47.728

7.  Age-related persistent clonal expansions of CD28(-) cells: phenotypic and molecular TCR analysis reveals both CD4(+) and CD4(+)CD8(+) cells with identical CDR3 sequences.

Authors:  A Colombatti; R Doliana; M Schiappacassi; C Argentini; E Tonutti; C Feruglio; P Sala
Journal:  Clin Immunol Immunopathol       Date:  1998-10

8.  Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations.

Authors:  Desirée Schubert; Claudia Bode; Rupert Kenefeck; Tie Zheng Hou; Lucy S K Walker; David M Sansom; Bodo Grimbacher; James B Wing; Alan Kennedy; Alla Bulashevska; Britt-Sabina Petersen; Alejandro A Schäffer; Björn A Grüning; Susanne Unger; Natalie Frede; Ulrich Baumann; Torsten Witte; Reinhold E Schmidt; Gregor Dueckers; Tim Niehues; Suranjith Seneviratne; Maria Kanariou; Carsten Speckmann; Stephan Ehl; Anne Rensing-Ehl; Klaus Warnatz; Mirzokhid Rakhmanov; Robert Thimme; Peter Hasselblatt; Florian Emmerich; Toni Cathomen; Rolf Backofen; Paul Fisch; Maximilian Seidl; Annette May; Annette Schmitt-Graeff; Shinji Ikemizu; Ulrich Salzer; Andre Franke; Shimon Sakaguchi
Journal:  Nat Med       Date:  2014-10-20       Impact factor: 53.440

9.  Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations.

Authors:  Tie Zheng Hou; Nisha Verma; Jennifer Wanders; Alan Kennedy; Blagoje Soskic; Daniel Janman; Neil Halliday; Behzad Rowshanravan; Austen Worth; Waseem Qasim; Helen Baxendale; Hans Stauss; Suranjith Seneviratne; Olaf Neth; Peter Olbrich; Sophie Hambleton; Peter D Arkwright; Siobhan O Burns; Lucy S K Walker; David M Sansom
Journal:  Blood       Date:  2017-02-03       Impact factor: 22.113

10.  Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee.

Authors:  Stuart G Tangye; Waleed Al-Herz; Aziz Bousfiha; Talal Chatila; Charlotte Cunningham-Rundles; Amos Etzioni; Jose Luis Franco; Steven M Holland; Christoph Klein; Tomohiro Morio; Hans D Ochs; Eric Oksenhendler; Capucine Picard; Jennifer Puck; Troy R Torgerson; Jean-Laurent Casanova; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2020-01-17       Impact factor: 8.317
View more
  2 in total

Review 1.  Human inborn errors of immunity to oncogenic viruses.

Authors:  Vivien Béziat; Emmanuelle Jouanguy
Journal:  Curr Opin Immunol       Date:  2021-08-05       Impact factor: 7.268

Review 2.  Evidence for altered host genetic factors in KSHV infection and KSHV-related disease development.

Authors:  Melissa J Blumenthal; Elena Maria Cornejo Castro; Denise Whitby; Arieh A Katz; Georgia Schäfer
Journal:  Rev Med Virol       Date:  2020-10-11       Impact factor: 6.989
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.